Jeppe Lange
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jeppe Lange has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Alma Becic Pedersen
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
4 shared publications - Anders Troelsen
Department of Orthopaedic Surgery, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark
4 shared publications Kjeld Søballe
Lundbeck Foundation Centre for Fast-track Hip and Knee Surgery, Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark; Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark
4 shared publications- Kjeld Søballe
Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, Denmark
4 shared publications B. Zerahn
Department of Clinical Physiology, Herlev Hospital, Herlev, Denmark
3 shared publications- Marianne Johansson Jørgensen
Department of Research, Horsens Regional Hospital, Horsens, Denmark and CAAIR (Collaboration on Applied AI Research and Innovation), Research Programme, Horsens Regional Hospital, Horsens, Denmark
3 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-15
From Model Cards to Subtle Care: Competing Logics of Ethics in Healthcare AI
- 2 October 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-15
Open AccessFrom Model Cards to Subtle Care: Competing Logics of Ethics in Healthcare AI
- Open Access
Physiotherapist-led education and exercise for patients with MRI-verified hip abductor tendon pathology: a prospective cohort study
Objectives: To investigate changes in lateral hip pain following a 3-month, physiotherapist-led, education and exercise programme in patients with clinically and MRI-verified hip abductor tendon pathology. Design: Prospective cohort study. Setting: Secondary care, Danish public teaching hospital. Participants: From May 2024 to July 2025, 60 patients (100% women) with lateral hip pain duration of >6 months, aged 18–75 years (mean age 58.2), MRI-verified hip abductor tendon pathology were included; 55 patients completed the intervention. Interventions: Patient education on load management and modification of daily activity was provided through seven physiotherapist-led sessions over 3 months. Additionally, patients followed an individually progressed daily home-based exercise programme. Primary and secondary outcome measures: The primary outcome was change in the subscale pain of the revised Copenhagen Hip and Groin Outcome Score (HAGOS). Secondary outcomes included hip-related patient-reported outcomes and health-related quality of life, isometric hip muscle strength and a 30-second Chair Stand Test (30s-CST). Results: Adherence to the exercise protocol was 85%. The mean (95% CI) score in the revised HAGOS pain improved from 46.4 (41.5 to 51.2) to 60.1 (54.4 to 65.7) at 3 months follow-up. Clinically relevant improvements were observed in secondary hip-related patient-reported outcomes, alongside improvements in generic patient-reported outcomes. Minor strength improvements were observed, while the 30s-CST improved from 11.7 (10.6 to 12.9) to 14.2 (12.8 to 15.6) repetitions. Conclusions: Following 3 months of physiotherapist-led, combined patient education and exercise therapy, patients with clinically and MRI-verified hip abductor tendon pathology, seen in secondary care, experienced clinically relevant changes in lateral hip pain measured by the revised HAGOS pain. Trial registration number: NCT06418217 .
Open AccessPhysiotherapist-led education and exercise for patients with MRI-verified hip abductor tendon pathology: a prospective cohort study
Objectives: To investigate changes in lateral hip pain following a 3-month, physiotherapist-led, education and exercise programme in patients with clinically and MRI-verified hip abductor tendon pathology. Design: Prospective cohort study. Setting: Secondary care, Danish public teaching hospital. Participants: From May 2024 to July 2025, 60 patients (100% women) with lateral hip pain duration of >6 months, aged 18–75 years (mean age 58.2), MRI-verified hip abductor tendon pathology were included; 55 patients completed the intervention. Interventions: Patient education on load management and modification of daily activity was provided through seven physiotherapist-led sessions over 3 months. Additionally, patients followed an individually progressed daily home-based exercise programme. Primary and secondary outcome measures: The primary outcome was change in the subscale pain of the revised Copenhagen Hip and Groin Outcome Score (HAGOS). Secondary outcomes included hip-related patient-reported outcomes and health-related quality of life, isometric hip muscle strength and a 30-second Chair Stand Test (30s-CST). Results: Adherence to the exercise protocol was 85%. The mean (95% CI) score in the revised HAGOS pain improved from 46.4 (41.5 to 51.2) to 60.1 (54.4 to 65.7) at 3 months follow-up. Clinically relevant improvements were observed in secondary hip-related patient-reported outcomes, alongside improvements in generic patient-reported outcomes. Minor strength improvements were observed, while the 30s-CST improved from 11.7 (10.6 to 12.9) to 14.2 (12.8 to 15.6) repetitions. Conclusions: Following 3 months of physiotherapist-led, combined patient education and exercise therapy, patients with clinically and MRI-verified hip abductor tendon pathology, seen in secondary care, experienced clinically relevant changes in lateral hip pain measured by the revised HAGOS pain. Trial registration number: NCT06418217 .
- Open Access
Placement-Dependent Accuracy of a Smartphone-Based Sensor Application Compared to an Accelerometer-Based System for Measuring Physical Activity in Healthy Adults: A Validation Study
Accurately monitoring physical activity, including stationary cycling on an exercise bike, is important in managing chronic diseases and rehabilitation after lower limb surgery. This study aimed to validate a new smartphone-based sensor application (the BeSAFE+) for activity recognition and step counting across five phone placements, using the SENS Motion® system as a reference standard, and observed activity time as ground truth. In a laboratory-based study, 20 participants performed walking, brisk walking, running, high- and low-intensity cycling, sitting, standing, and lying activities while carrying five smartphones placed in the front and back trouser pockets, a backpack, a running armband, and a fanny pack, and wearing the activity tracker. The front pocket placement had the most accurate classification during cycling activities (89–93%) versus SENS Motion® (96–98%). For other activities, the highest overall classification accuracy was achieved with the phone in the back pocket. Overall, the SENS Motion® activity tracker demonstrated higher classification accuracy than most smartphone placements across all activities, except for running. Nevertheless, several smartphone placements and Application Programming Interface (API) approaches achieved activity recognition and step count estimates that were not significantly different from the SENS Motion® activity tracker, indicating that smartphone-based activity recognition can be valid under specific conditions.
Open AccessPlacement-Dependent Accuracy of a Smartphone-Based Sensor Application Compared to an Accelerometer-Based System for Measuring Physical Activity in Healthy Adults: A Validation Study
Accurately monitoring physical activity, including stationary cycling on an exercise bike, is important in managing chronic diseases and rehabilitation after lower limb surgery. This study aimed to validate a new smartphone-based sensor application (the BeSAFE+) for activity recognition and step counting across five phone placements, using the SENS Motion® system as a reference standard, and observed activity time as ground truth. In a laboratory-based study, 20 participants performed walking, brisk walking, running, high- and low-intensity cycling, sitting, standing, and lying activities while carrying five smartphones placed in the front and back trouser pockets, a backpack, a running armband, and a fanny pack, and wearing the activity tracker. The front pocket placement had the most accurate classification during cycling activities (89–93%) versus SENS Motion® (96–98%). For other activities, the highest overall classification accuracy was achieved with the phone in the back pocket. Overall, the SENS Motion® activity tracker demonstrated higher classification accuracy than most smartphone placements across all activities, except for running. Nevertheless, several smartphone placements and Application Programming Interface (API) approaches achieved activity recognition and step count estimates that were not significantly different from the SENS Motion® activity tracker, indicating that smartphone-based activity recognition can be valid under specific conditions.
- Open Access
- 28 February 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 397, 119135
Tailored AI ethics: Enacting geriatric care with AI-based patient monitoring
- 28 February 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 397, 119135
Open AccessTailored AI ethics: Enacting geriatric care with AI-based patient monitoring
- Open Access
Physiotherapist-led education and exercise for patients with MRI-verified hip abductor tendon pathology: a protocol for a prospective cohort study
Introduction Lateral hip pain due to hip abductor tendon pathology (ie, gluteal tendinopathy or tendon rupture) is a relatively new diagnosis. This patient group has previously been described as a clinical dilemma due to the often-short-lived effects of treatment. In the process of identifying the underlying pathology, however, more targeted treatment strategies have been explored. Recent research recommends exercise as a first-line treatment for this patient group along with patient education. However, patients seen in a hospital setting (secondary healthcare) often present recalcitrant lateral hip pain, tendon ruptures and multiple comorbidities. Whether patient education and exercise therapy are beneficial for patients in secondary healthcare has only been sparsely investigated. Therefore, this study aims to investigate changes in lateral hip pain following a 3 month physiotherapist-led patient education and exercise intervention in patients with MRI-proven hip abductor tendon pathology seen in a hospital setting. Methods and analysis In this prospective cohort trial, 60 patients, presenting lateral hip pain and MRI-verified hip abductor tendon pathology at the orthopaedic outpatient clinic at Horsens Regional Hospital, Denmark, a public teaching hospital, are included. Hip abductor tendon pathology will be diagnosed by clinical tests and MRI. The intervention consists of seven physiotherapist-led patient education and exercise sessions at the hospital during 3 months. The instructions will guide the patients in their daily home-based exercise sessions. The primary outcome is change in lateral hip pain measured by the ‘pain’ subscale from the patient-reported outcome measure: the revised Copenhagen Hip And Groin Outcome Score (HAGOS). Secondary outcomes are changes in the remaining subscales of the revised HAGOS, Oxford Hip Score, Victorian Institute of Sports Assessment-Gluteal Questionnaire, European Questionnaire-Five Dimensions Five-Level, lateral hip pain (numeric rating scale score, 0–10), hip muscle strength and the 30 s chair stand test. Also, patient-reported Global Rating of Change in hip condition, as well as adherence and harms, will be reported. Ethics and dissemination This trial has been accepted by the Central Denmark Regions Ethics Committee (1-10-72-136-22). The study is registered at the Central Denmark Region List of Research Projects (Journal No 1-16-02-180-24) and clinicaltrials.gov (NCT06418217). All results from this study, regardless of the direction, will be published in a peer-reviewed journal and presented at national and international congresses. Trial registration number NCT06418217.
Open AccessPhysiotherapist-led education and exercise for patients with MRI-verified hip abductor tendon pathology: a protocol for a prospective cohort study
Introduction Lateral hip pain due to hip abductor tendon pathology (ie, gluteal tendinopathy or tendon rupture) is a relatively new diagnosis. This patient group has previously been described as a clinical dilemma due to the often-short-lived effects of treatment. In the process of identifying the underlying pathology, however, more targeted treatment strategies have been explored. Recent research recommends exercise as a first-line treatment for this patient group along with patient education. However, patients seen in a hospital setting (secondary healthcare) often present recalcitrant lateral hip pain, tendon ruptures and multiple comorbidities. Whether patient education and exercise therapy are beneficial for patients in secondary healthcare has only been sparsely investigated. Therefore, this study aims to investigate changes in lateral hip pain following a 3 month physiotherapist-led patient education and exercise intervention in patients with MRI-proven hip abductor tendon pathology seen in a hospital setting. Methods and analysis In this prospective cohort trial, 60 patients, presenting lateral hip pain and MRI-verified hip abductor tendon pathology at the orthopaedic outpatient clinic at Horsens Regional Hospital, Denmark, a public teaching hospital, are included. Hip abductor tendon pathology will be diagnosed by clinical tests and MRI. The intervention consists of seven physiotherapist-led patient education and exercise sessions at the hospital during 3 months. The instructions will guide the patients in their daily home-based exercise sessions. The primary outcome is change in lateral hip pain measured by the ‘pain’ subscale from the patient-reported outcome measure: the revised Copenhagen Hip And Groin Outcome Score (HAGOS). Secondary outcomes are changes in the remaining subscales of the revised HAGOS, Oxford Hip Score, Victorian Institute of Sports Assessment-Gluteal Questionnaire, European Questionnaire-Five Dimensions Five-Level, lateral hip pain (numeric rating scale score, 0–10), hip muscle strength and the 30 s chair stand test. Also, patient-reported Global Rating of Change in hip condition, as well as adherence and harms, will be reported. Ethics and dissemination This trial has been accepted by the Central Denmark Regions Ethics Committee (1-10-72-136-22). The study is registered at the Central Denmark Region List of Research Projects (Journal No 1-16-02-180-24) and clinicaltrials.gov (NCT06418217). All results from this study, regardless of the direction, will be published in a peer-reviewed journal and presented at national and international congresses. Trial registration number NCT06418217.
- 29 August 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (20) , 2243-2250
Fifteen-Year Mortality Following Periprosthetic Joint Infection in Total Knee Arthroplasty
Background: Periprosthetic joint infection (PJI) following total knee arthroplasty (TKA) is a serious complication associated with notable loss of function, impaired quality of life, and excess short-term mortality. In this study, we aimed to report the impact of PJI on long-term mortality and its associated risk factors. Methods: Using data from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), we used Kaplan-Meier estimates of survivorship and standardized mortality ratios (SMRs) based on Australian period life tables to describe mortality rates following revision for PJI, aseptic revisions (excluding those for fracture), and unrevised primary TKA. Additionally, hazard ratios (HRs) were calculated with multivariable proportional hazard models to assess the impact of the risk factors of age, gender, comorbidities, and minor versus major revisions. Results: Among 867,113 TKA procedures overall, there were 8,642 first revisions for PJI and 25,328 aseptic first revisions. At 5, 10, and 15 years, 16.1%, 34.4%, and 53.4% of patients with revision for PJI had died. When compared with a matched population, the SMR for revision for PJI was 1.33 (95% confidence interval [CI]: 1.28 to 1.39); for aseptic revision, 0.84 (95% CI: 0.82 to 0.87); and for unrevised primary TKA, 0.79 (95% CI: 0.78 to 0.79). Increasing age and higher American Society of Anesthesiologists (ASA) scores were significant mortality risk factors. Major revisions for PJI were not associated with a greater mortality risk compared with minor revisions for PJI. Conclusions: Patients with revision for PJI had a 33% greater-than-expected mortality. There was a high mortality in the early postoperative period, and the excess mortality risk persisted beyond 15 years. Increasing age and higher ASA scores were associated with increased mortality. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
- 29 August 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (20) , 2243-2250
Fifteen-Year Mortality Following Periprosthetic Joint Infection in Total Knee Arthroplasty
Background: Periprosthetic joint infection (PJI) following total knee arthroplasty (TKA) is a serious complication associated with notable loss of function, impaired quality of life, and excess short-term mortality. In this study, we aimed to report the impact of PJI on long-term mortality and its associated risk factors. Methods: Using data from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), we used Kaplan-Meier estimates of survivorship and standardized mortality ratios (SMRs) based on Australian period life tables to describe mortality rates following revision for PJI, aseptic revisions (excluding those for fracture), and unrevised primary TKA. Additionally, hazard ratios (HRs) were calculated with multivariable proportional hazard models to assess the impact of the risk factors of age, gender, comorbidities, and minor versus major revisions. Results: Among 867,113 TKA procedures overall, there were 8,642 first revisions for PJI and 25,328 aseptic first revisions. At 5, 10, and 15 years, 16.1%, 34.4%, and 53.4% of patients with revision for PJI had died. When compared with a matched population, the SMR for revision for PJI was 1.33 (95% confidence interval [CI]: 1.28 to 1.39); for aseptic revision, 0.84 (95% CI: 0.82 to 0.87); and for unrevised primary TKA, 0.79 (95% CI: 0.78 to 0.79). Increasing age and higher American Society of Anesthesiologists (ASA) scores were significant mortality risk factors. Major revisions for PJI were not associated with a greater mortality risk compared with minor revisions for PJI. Conclusions: Patients with revision for PJI had a 33% greater-than-expected mortality. There was a high mortality in the early postoperative period, and the excess mortality risk persisted beyond 15 years. Increasing age and higher ASA scores were associated with increased mortality. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 6 August 2025
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 204, 106065
Ethics in Danish healthcare AI policy: A document analysis
- 6 August 2025
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 204, 106065
Open AccessEthics in Danish healthcare AI policy: A document analysis
- Open Access
- 10 July 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-10
Generic health status improves after non-surgically and surgically treated hip abductor tendon pathology: a retrospective study of ninety-seven female patients
Insertional hip abductor tendon pathology (tendinopathy or tears of gluteus medius and/or minimus tendons) are increasingly recognized as the main cause of lateral hip pain. This study aims to evaluate generic health status in patients with lateral hip pain due to Magnetic Resonance Imaging (MRI) verified hip abductor tendon pathology using the EQ-5D-5L and compare these findings with a matched national population norm. Data from patients with lateral hip pain, referred to our hospital from 2017-2023, was retrospectively reviewed. Females aged 18+ years, with positive clinical tests and MRI verified hip abductor tendon pathology, who had completed the EQ-5D-5L at relevant timepoints, were included. Our treatment algorithm consisted of a baseline physiotherapist led intervention (patient education followed by 3-months un-supervised training). Surgery was offered to patients who, after the intervention, had recalcitrant lateral hip pain and MRI verified tendon tears. Post hoc two treatment groups were identified. The EQ-index scores were calculated from individual health profiles using a national value set. The student’s t-test was used to compare groups. Summary statistics are used, including numbers of patients and proportions of categorical responses for the five EQ-5D dimensions. To compare responses between groups, the Fisher’s exact test was used. Ninety-seven female patients were included; 48 (57±12 years) received rehabilitation only (REHAB) and 49 (59±11 years) underwent subsequent surgery (SURG). At baseline, the mean EQ-index was inferior to population norms. After 3 months of rehabilitation, EQ-index (p<0.0001) and EQ-VAS (p=0.004) improved in REHAB, but not in SURG (EQ-index: p=0.32, EQ-VAS: p=0.22). Twelve months after surgery, EQ-index (p<0.0001) and EQ-VAS (p<0.0001) improved and, notably, the dimension “pain/discomfort” was comparable to population norms (p=0.788). Generic health status in female patients suffering from lateral hip pain due to hip abductor tendon pathology is severely affected compared to a national population norm measured with the EQ-5D-5L. Generic health status may improve after three months of patient education and rehabilitation in some cases, while surgery may improve health status three months postoperative in the remaining cases. The study is registered at the Central Denmark Region List of Research Projects (Jr nr: 1-16-02-761-17 and 1-16-02-125-19). Findings Implications Cautions
- 10 July 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-10
Open AccessGeneric health status improves after non-surgically and surgically treated hip abductor tendon pathology: a retrospective study of ninety-seven female patients
Insertional hip abductor tendon pathology (tendinopathy or tears of gluteus medius and/or minimus tendons) are increasingly recognized as the main cause of lateral hip pain. This study aims to evaluate generic health status in patients with lateral hip pain due to Magnetic Resonance Imaging (MRI) verified hip abductor tendon pathology using the EQ-5D-5L and compare these findings with a matched national population norm. Data from patients with lateral hip pain, referred to our hospital from 2017-2023, was retrospectively reviewed. Females aged 18+ years, with positive clinical tests and MRI verified hip abductor tendon pathology, who had completed the EQ-5D-5L at relevant timepoints, were included. Our treatment algorithm consisted of a baseline physiotherapist led intervention (patient education followed by 3-months un-supervised training). Surgery was offered to patients who, after the intervention, had recalcitrant lateral hip pain and MRI verified tendon tears. Post hoc two treatment groups were identified. The EQ-index scores were calculated from individual health profiles using a national value set. The student’s t-test was used to compare groups. Summary statistics are used, including numbers of patients and proportions of categorical responses for the five EQ-5D dimensions. To compare responses between groups, the Fisher’s exact test was used. Ninety-seven female patients were included; 48 (57±12 years) received rehabilitation only (REHAB) and 49 (59±11 years) underwent subsequent surgery (SURG). At baseline, the mean EQ-index was inferior to population norms. After 3 months of rehabilitation, EQ-index (p<0.0001) and EQ-VAS (p=0.004) improved in REHAB, but not in SURG (EQ-index: p=0.32, EQ-VAS: p=0.22). Twelve months after surgery, EQ-index (p<0.0001) and EQ-VAS (p<0.0001) improved and, notably, the dimension “pain/discomfort” was comparable to population norms (p=0.788). Generic health status in female patients suffering from lateral hip pain due to hip abductor tendon pathology is severely affected compared to a national population norm measured with the EQ-5D-5L. Generic health status may improve after three months of patient education and rehabilitation in some cases, while surgery may improve health status three months postoperative in the remaining cases. The study is registered at the Central Denmark Region List of Research Projects (Jr nr: 1-16-02-761-17 and 1-16-02-125-19). Findings Implications Cautions
- Open Access
- 29 August 2023
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 24 (1) , 1-7
The value of sonication on orthopaedic implants in an everyday clinical setting – an exploratory study
Background: Sonication of removed orthopaedic implants in suspected implant-associated infections (IAI) is widely applied internationally. However, evaluation of the utility of sonication on all implants removed in everyday standard practice is scarce. This exploratory study was performed to evaluate the application of sonication fluid (SF) culture on removed orthopaedic implants, irrespective of the reason for removal. Methods: Out of 100 removed orthopaedic implants collected between August 2019 and September 2020, 77 implants with availability of concurrent tissue culture samples were included in the study. Removed implants were categorized into a confirmed or suspected IAI group and a presumed aseptic group based on pre-operative diagnosis by the responsible surgeon. Implants were sonicated and SF culture performed under both aerobic and anaerobic conditions. The significance of all bacterial isolates was evaluated based on the CFU/mL cut-offs of the EBJIS guidelines, except for C. acnes where additional investigations were performed. Results: The results of SF culture in the two groups were compared with their corresponding tissue cultures. Out of the 12 cases in the confirmed/suspected IAI group, SF culture was positive in 11 cases and had increased diagnostic yield in two (17%) cases compared to tissue culture. Increased diagnostic yield of SF compared to tissue culture was seen in seven (11%) of the 65 implants in the presumed aseptic group. If growth of Cutibacterium species isolates were interpreted based on EBJIS cut-off for SF culture instead of the study-specific criteria, then two isolates considered to represent infection might have been missed while three other isolates considered contaminants would have fallen under the ‘infection confirmed’ category in the EBJIS guidelines. Conclusion: Sonication with SF culture has increased diagnostic yield compared to tissue cultures in all implants irrespective of reason for removal. However, positive SF cultures with Cutibacterium species should always be interpreted with extreme care.
- 29 August 2023
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 24 (1) , 1-7
Open AccessThe value of sonication on orthopaedic implants in an everyday clinical setting – an exploratory study
Background: Sonication of removed orthopaedic implants in suspected implant-associated infections (IAI) is widely applied internationally. However, evaluation of the utility of sonication on all implants removed in everyday standard practice is scarce. This exploratory study was performed to evaluate the application of sonication fluid (SF) culture on removed orthopaedic implants, irrespective of the reason for removal. Methods: Out of 100 removed orthopaedic implants collected between August 2019 and September 2020, 77 implants with availability of concurrent tissue culture samples were included in the study. Removed implants were categorized into a confirmed or suspected IAI group and a presumed aseptic group based on pre-operative diagnosis by the responsible surgeon. Implants were sonicated and SF culture performed under both aerobic and anaerobic conditions. The significance of all bacterial isolates was evaluated based on the CFU/mL cut-offs of the EBJIS guidelines, except for C. acnes where additional investigations were performed. Results: The results of SF culture in the two groups were compared with their corresponding tissue cultures. Out of the 12 cases in the confirmed/suspected IAI group, SF culture was positive in 11 cases and had increased diagnostic yield in two (17%) cases compared to tissue culture. Increased diagnostic yield of SF compared to tissue culture was seen in seven (11%) of the 65 implants in the presumed aseptic group. If growth of Cutibacterium species isolates were interpreted based on EBJIS cut-off for SF culture instead of the study-specific criteria, then two isolates considered to represent infection might have been missed while three other isolates considered contaminants would have fallen under the ‘infection confirmed’ category in the EBJIS guidelines. Conclusion: Sonication with SF culture has increased diagnostic yield compared to tissue cultures in all implants irrespective of reason for removal. However, positive SF cultures with Cutibacterium species should always be interpreted with extreme care.
- Open Access
Effect of single versus multiple prophylactic antibiotic doses on prosthetic joint infections following primary total hip arthroplasty in patients with osteoarthritis at public and private hospitals in Denmark: protocol for a nationwide cross-over, cluster randomised, non-inferiority trial [The Pro-Hip-Quality Trial]
Introduction A feared complication after total hip arthroplasty (THA) is prosthetic joint infection (PJI), associated with high morbidity and mortality. Prophylactic antibiotics can reduce the risk of PJI. However, there is no consensus on the dosages and current recommendations are based on a low evidence level. The objective is to compare the effect of a single versus multiple doses of prophylactic antibiotics administered within 24 hours on PJI. Methods and analysis The study is designed as a cross-over, cluster randomised, non-inferiority trial. All clinical centres use both antibiotic practices (1 year of each intervention). All Danish orthopaedic surgery departments will be involved: Based on quality databases, 2-year cohorts of approximately 20 000 primary THAs conducted at 39 public and private hospitals, will be included. Inclusion criteria: age ≥18 years, all indications for THA except patients operated due to acute or sequelae from proximal femoral or pelvic fractures or bone tumour or metastasis. The primary outcome is PJI within 90 days after primary THA. Secondary outcomes include (1) serious adverse events, (2) potential PJI, (3) length of hospitalisation stay, (4) cardiovascular events, (5) hospital-treated infections, (6) community-based antibiotic use, (7) opioid use and (8) use of acetaminophen and non-steroidal anti-inflammatory drugs. All outcome measures will be extracted from national databases. Analyses will be based on the intention-to-treat population. Non-inferiority will be shown if the upper limit of the two-sided 95% CI for the OR is less than 1.32 for the single dose as compared with multiple doses. The results will establish best practice on antibiotic prophylaxis dosages in the future. Ethics and dissemination This study has been approved by Committees on Health Research Ethics for The Capital Region of Denmark (21069108) and The Danish Medicines Agency (2021091723). All results will be presented in peer-reviewed medical journals and international conferences. Trial registration number NCT05530551.
Open AccessEffect of single versus multiple prophylactic antibiotic doses on prosthetic joint infections following primary total hip arthroplasty in patients with osteoarthritis at public and private hospitals in Denmark: protocol for a nationwide cross-over, cluster randomised, non-inferiority trial [The Pro-Hip-Quality Trial]
Introduction A feared complication after total hip arthroplasty (THA) is prosthetic joint infection (PJI), associated with high morbidity and mortality. Prophylactic antibiotics can reduce the risk of PJI. However, there is no consensus on the dosages and current recommendations are based on a low evidence level. The objective is to compare the effect of a single versus multiple doses of prophylactic antibiotics administered within 24 hours on PJI. Methods and analysis The study is designed as a cross-over, cluster randomised, non-inferiority trial. All clinical centres use both antibiotic practices (1 year of each intervention). All Danish orthopaedic surgery departments will be involved: Based on quality databases, 2-year cohorts of approximately 20 000 primary THAs conducted at 39 public and private hospitals, will be included. Inclusion criteria: age ≥18 years, all indications for THA except patients operated due to acute or sequelae from proximal femoral or pelvic fractures or bone tumour or metastasis. The primary outcome is PJI within 90 days after primary THA. Secondary outcomes include (1) serious adverse events, (2) potential PJI, (3) length of hospitalisation stay, (4) cardiovascular events, (5) hospital-treated infections, (6) community-based antibiotic use, (7) opioid use and (8) use of acetaminophen and non-steroidal anti-inflammatory drugs. All outcome measures will be extracted from national databases. Analyses will be based on the intention-to-treat population. Non-inferiority will be shown if the upper limit of the two-sided 95% CI for the OR is less than 1.32 for the single dose as compared with multiple doses. The results will establish best practice on antibiotic prophylaxis dosages in the future. Ethics and dissemination This study has been approved by Committees on Health Research Ethics for The Capital Region of Denmark (21069108) and The Danish Medicines Agency (2021091723). All results will be presented in peer-reviewed medical journals and international conferences. Trial registration number NCT05530551.